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Abstract: Concern about the health effects of extremely low frequency
(ELF) magnetic fields (MF) has been raised by epidemiological studies
indicating an association between certain cancers and living near power
lines or working in high electric field environments. Alterations in
pineal function have been proposed as a mechanism through which
power-frequency MFs may interact with living organisms. A double
blind laboratory study was performed to evaluate daytime exposure
effects of 100 T root mean square (rms) 50 Hz MF. Three head
exposure sessions of 30 min each were performed: sham, continuous,
and intermittent (15 s on/off cycles) MFs were presented to each
subject in early or late afternoon (13:30 or 16:30 hr). Twenty-one
healthy male volunteers (20–27 yr old) participated in these 3-weekly
experimental conditions. Blood samples were drawn for serum
melatonin measurement, hourly at night (from 20:00 to 07:00 hr) under
controlled environmental conditions. Urinary excretion of
6-sulfatoxymelatonin (aMT6s), the main melatonin metabolite, was
measured for a 17 hr period, by means of urine samples taken at 19:00
hr (14:00–19:00 hr ‘‘afternoon period’’), 23:00 hr (19:00–23:00 hr
‘‘evening period’’), and 07:00 hr, day 2 (23:00–07:00 hr day 2
‘‘night-time period’’). There were no significant differences in either
plasma melatonin or in aMT6s excretion profiles in the three
experimental conditions. However, a tendency for a smaller increase of
night-time urinary aMT6s after continuous MF exposure was found
(P=0.08) particularly in men with the lower excretion rate of aMT6s
(‘‘Low Group’’) (P=0.07). We conclude that this study does not
indicate that daytime acute MF exposure influences either melatonin
secretion or aMT6s excretion. Inter-individual differences in pineal
production of melatonin, however, have to be taken into account in
further studies.
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Introduction
For nearly 20 yrs, there has been concern about
the health effects of extremely low frequency
(ELF) magnetic fields (MF), raised by epidemio-
logical studies indicating an association between
certain cancers and living near power lines or
working in a high electric field environment [Por-
tier and Wolfe, 1999]. Most studies have reported
a relatively small risk, but the extensive use of
electric power could result in substantial conse-
quences for public health. Stevens in 1987, and
later Stevens et al. [1992, 1997], and Stevens and
Scott [1996] formulated the melatonin hypothesis
which assumes that MF and electric fields may act
to suppress the pineal melatonin production of
melatonin which, in turn, influences breast
carcinogenesis.
Wilson [1988] postulated that if long-term expo-
sure to ELF fields causes pineal dysfunction in
human beings, the changes may contribute to the
onset of depression or exacerbate existing depres-
sive disorders. The melatonin hypothesis currently
represents one of the most well cited plausible
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mechanisms by which EMF exposure could lead
to several outcomes [Crasson et al., 1992; Reiter
1993, 1995; Lambrozo et al., 1996; Stevens et al.,
1997; Reiter 1998]. Physiological and/or pharma-
cological levels of melatonin have been shown to
modulate a variety of biological processes which
are related to the regulation of circadian rhythms,
seasonal reproduction, sleep, free radical scaveng-
ing, metabolism, immunity, and neoplasia [Brzen-
zinski, 1997]. Weak power-frequency MFs (60 Hz
in the US, 50 Hz in most other countries) have
also been implicated in reducing or time-shifting
pineal melatonin production, its metabolite or
pineal N-acetyltransferase activity in some ani-
mals. However, this was not found in all studies
and depends on the species (rodents, dairy cows,
lambs, or in non-human primates) and experimen-
tal protocol [review in Portier and Wolfe, 1998].
Only two animal studies describe a significant in-
crease in serum melatonin concentration or in
urinary 6-sulfatoxymelatonin (aMT6s) excretion
after MF exposure, and this is explained as re-
bound phenomenon [Bakos et al., 1997; Niehaus
et al., 1997]. A few studies have been conducted
using humans. MF exposure in these experiments
generally ranged from 1 to 30 T root mean
square (rms) and was presented at night-time. The
first study of the Midwest Research Institute indi-
cated a significant suppression of night-time mela-
tonin levels with intermittent 60 Hz MF exposure
in a sub-group of subjects whose melatonin secre-
tion was lower than normal. However, these re-
sults were not replicated in a follow-up study
[Graham et al., 1996] nor in the recent study
[Graham et al., 2000] or in a study where men
were exposed to MF continuously, rather than
intermittently throughout the night [Graham et
al., 1997]. Likewise, Selmaoui et al. [1996] found
no difference in serum melatonin levels or in 6-hy-
droxymelatonin sulfate (6-OHMS) excretion in ex-
posed men compared with control subjects during
night-time continuous or intermittent 50 Hz lin-
early polarized MF of 10 Trms. Only one study
indicated changes in plasma melatonin profiles,
when exposure preceded onset of the rise in mela-
tonin concentration [Wood et al., 1998].
Some studies have been undertaken in real life
conditions, among electric utility workers [Burch
et al., 1998, 1999], Swiss railway workers [Pfluger
and Minder, 1996], video display unit workers
[Arnetz and Berg, 1996] or among nightly electric
blanket users [Wilson et al., 1990]. They indicate
slight alterations in the urinary excretion of the
melatonin metabolite after daytime exposure to
MF; however, the perturbations were not consis-
tent across studies, which were subjected to con-
founding bias like differential light exposure.
More recently, Juutilainen et al. [2000] undertook
a study to determine if daytime occupational ex-
posure to MF alters nocturnal melatonin produc-
tion in humans. They showed lower average
6-hydroxymelatonin sulfate (6-OHMS) among
garment industry workers than in the reference
group.
Although no theoretical or biophysical rationale
is provided for why or how brief head exposure,
when melatonin is almost non-existent in the cir-
culation, could influence subsequent night-time se-
cretion of this hormone that is released from the
pineal into the circulation almost as quickly as it is
produced, laboratory study has been conducted to
test power-frequency daytime exposure in humans.
In the present report, we describe the results of a
double blind human study designed to determine
whether daytime exposure to 100 Trms 50 Hz
MF can affect melatonin secretion and urinary
aMT6s excretion in healthy humans. The question
of intermittent vs. continuous exposure to MF has
not been resolved [Graham et al., 1996, 1997], so
the study population was subjected to three differ-
ent head exposures, one sham condition and two
real MF exposures: continuous (field on for 30
min) and intermittent (field 15 s on/off for 30
min). We chose a field-strength (100 Trms) simi-
lar to that in the proximity of some household and
industrial electrical appliances. Other parameters
were assessed in this study (psychological and psy-
chophysiological) and are described elsewhere
[Crasson et al., 1999].
Material and methods
Subjects
Twenty-nine male subjects were recruited for this
study. They were aged from 20 to 35 yrs old and
most of them were local university students or
local residents, a region centred around 50°50.
Each was offered a complete and accurate descrip-
tion of the aims, risks, and benefits of the study
and was submitted to psychological (self-reported
scales) and physical (medical and biological) ex-
aminations. Four subjects were excluded because
of biological abnormalities (blood analysis) and
one because of psychophysiological recording
difficulties in the pre-tests. One discontinued after
the first exposure session because of anticipated
anxiety and subjective complaints of concentration
difficulties, hypersomnia and excessive fatigue feel-
ings attributed to the presumed MF exposure.
Upon opening of the exposure order codes, the
subject had been sham exposed. The data of two
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subjects were deleted from the analysis when
equipment problems invalidated 1 day of the
experiment.
The remaining 21 subjects met all requirements
for the study: good general health, normal weight,
no history of chronic disease or neurologic or
psychiatric illness, no medication use, no alcohol,
drug or tobacco (20 cigarettes/day) abuse and
no metal intra-cranial prosthesis or implant. They
were instructed to eat balanced meals and were
not allowed to drink alcohol or caffeine 12 hr
before and after each experimental day.
The mean age was 232 (range, 20–27 yr). The
Institutional Ethics Board approved this study,
and informed consent was obtained from all
subjects.
Exposure facility and study design
The exposure facility has been described previ-
ously [Crasson et al., 1999]. In summary, the sinu-
soidally MFs linearly polarized, were generated by
a ‘‘magnetic helmet’’ specifically designed and con-
structed for this experiment by the Department of
Applied Electricity (University of Lie`ge, Belgium,
W. Legros and P. Scarpa) to expose the human
head to maximally reduced electric fields and ho-
mogeneous 50 Hz MF. It is a cubic structure
formed by six Helmoltz coils, 35 cm in diameter,
distributed in the three orthogonal directions al-
lowing human cephalic exposure. Each axis of the
MF can be independently energized from an ad-
justable transformer. For both real exposure ses-
sions (continuous and intermittent), two pairs of
coils were energized, in phase, to produce a uni-
form oblique 100 Trms 50 Hz MF which, be-
cause of the physical installation of the apparatus,
was parallel to the direction of the local geomag-
netic field.
For the intermittent exposure, an automatic
time switch operated the temporal cycle. A relay
was operated every 15 s without consideration of
voltage or current zero crossing. Therefore, some
transients existed in the generated MF, although
their magnitude was limited by the, mainly, induc-
tive electrical circuit.
For the continuous exposure, the time switch
was off and MF was presented without disconnec-
tion during the entire exposure session. In sham
exposure, the field was off during the whole expo-
sure session. Ambient alternative current (AC)
field strength in the experimental room was
checked using an EMDEX II (Enertech-EPRI)
dosimeter and was 0.06 Trms. Local geomag-
netic field (DC field), measured with a Gaussmeter
RFL912, was 40 Trms at an inclination of 60° N.
The double blind strategy assumed that subjects
were randomly assigned to exposure order, and
the field generated by an operator not involved in
the study nor present during the exposure and
testing sessions. Each subject participated in three
30 min exposure sessions, spaced 1 wk apart. The
experimental conditions consisted of one sham
field condition and two real MF exposure condi-
tions; one continuous (field on for 30 min) and one
intermittent exposure (field 15 s on/off for 30 min).
MF amplitude was set at 100 Trms at 50 Hz. A
preliminary study showed that the volunteers did
not perceive the MF generated by the ‘‘magnetic
helmet’’ [Crasson et al., 1993]. However, after each
exposure session, subjects noted whether the fields
were on or off and were asked upon which indices
they had based their judgements. They noted their
responses on a field detection questionnaire, a
French adaptation of the Field Status Question-
naire (FSQ) [Cook et al., 1992].
Each of the 21 subjects participated in the 3-
weekly experimental sessions. In order to test a
maximum number of volunteers in the same sea-
son, two subjects were exposed each afternoon.
Thus, from the 21 subjects, 10 were exposed at
13:30 hr and 11 at 16:30 hr. They arrived 30 min
before the exposure session and remained in the
hospital until the next morning. They went in their
sleeping room at 19:00–07:00 hr for blood and
urinary sample collection, in controlled lighting
conditions. Between 20:00 and 23:00 hr, lighting
was set at 50 lux to provide the opportunity to
read or study. Subjects were not allowed to watch
television to control for electromagnetic field ex-
posure and lighting differences. Sleeping was al-
lowed only while the lights were off, between 23:00
and 07:00 hr. During this time, a 5 lux light was
kept on in the corridor to permit blood sampling
without interfering with melatonin production.
Data collection and radioimmunoassay
Blood samples and urinary collections were per-
formed in this study. At 19:50 hr, for blood sam-
pling, an indwelling catheter was inserted into an
antecubital vein. The intravenous line was kept
patent with a slow drip of heparinized saline.
Blood samples were drawn at hourly intervals over
a 12 hr period from 20:00 to 07:00 hr. At every
sampling, 5 ml of blood was collected through a
three-way stopcock, immediately transferred to
heparinized plastic tubes, and stored at 4°C before
being centrifuged and stored at −20°C until
analysis.
Urinary excretion of aMT6s, was measured for
a 17 hr period, through urine samples provided at
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19:00 (14:00–19:00 hr, ‘‘afternoon period’’), 23:00
(19:00–23:00 hr, ‘‘evening period’’) and 07:00 hr
day 2 (23:00–07:00 hr day 2, ‘‘night-time period’’).
Total urine volumes were measured for each sam-
pling period. Each urine sample was immediately
frozen at −20°C. All samples were collected from
March to June.
Urine and blood samples were analysed by ra-
dioimmunoassay (RIA). Assays were done within
6 months after collection. A double blind proce-
dure was installed and samples were coded so that
personnel who conducted the RIAs were unaware
of whether blood samples were from real or sham
exposure days. All samples from a given partici-
pant were analysed in the same assay by RIA
methods described previously [Claustrat et al.,
1984; Harthe´ et al., 1991]. The sensitivity of the
melatonin assay was 5 pg/mL. For 100 pg/mL
melatonin, the intra- and inter-assay coefficients of
variation (CV) were 4 and 10.5%, respectively
(n=20). Plasma melatonin concentrations are ex-
pressed in pg/mL. The maximum melatonin level
was defined as the highest melatonin level
recorded for a subject for the night (from 20:00 to
07:00 hr). The peak time was the time at which the
maximum melatonin level occurred. For an
aMT6s concentration of 300 pmol/L, the intra-as-
say CV was 8% and the inter-assay CV was 12%.
aMT6s values are expressed by the average hourly
excretion (ng/hr) for each sampling period (after-
noon, evening and night-time periods).
Statistical analysis
MF exposure effect was defined as the difference
in urinary aMT6s or plasma melatonin concentra-
tions measured after the sham and the two real
MF exposures at any period of sampling. The
differences were tested using a three-way repeated
measure analysis of variance (ANOVA-R).
ANOVA for repeated measurements was applied
to reveal inter- and intra-individual differences in
melatonin secretion and aMT6s excretion. Post-
hoc analysis was conducted when significant re-
sults emerged to specifically determine between
which conditions the statistical differences oc-
curred. Exposure time (13:30 vs. 16:30 hr) was
included in the analysis as a covariable. Additional
ANOVAs were computed with the order level as
between subject factors, therefore, checking the
effectiveness of the counterbalancing procedure.
All statistical hypotheses were tested at the P-
value 0.05 level of significance. Results obtained
were expressed as mean  S.E.M. Regression anal-
ysis was used for plasma melatonin and urinary
aMT6s correlation studies. The 2 non-parametric
test was used to analyse FSQ data.
Results
The FSQ data indicated that subjects were unable
to detect the presence of the MF in the helmet in
the two experiments [Crasson et al., 1999].
The night-time melatonin plasma concentra-
tions (from 22:00 to 06:00 hr) as well as the
maximum melatonin level, are highly correlated
with night-time urinary aMT6s levels (from 23:00
to 07:00 hr period), with the highest correlation
coefficient at 02:00 hr; r=0.83 (P=0.0001, F=
41.66, d.f.=1.20).
A total of 755 blood samples were collected
from the 21 subjects exposed in the three experi-
mental sessions. Only two sets of data are missing
(20:00 hr sampling for two subjects in one
condition).
Fig. 1 shows group average levels and S.E.M. of
plasma melatonin concentrations every hour from
20:00 to 07:00 hr for sham condition, continuous,
and intermittent MF exposures. The secretory
profile shows that melatonin production increases
in the evening, corresponding to the onset of dark-
ness, peaks in the middle of the night (between
03:00 and 04:00 hr), and gradually falls during the
second half of the night, in the three experimental
conditions. Large inter-individual variations are
exhibited compared with the intra-individual vari-
ations, as described in the literature [Bergiannaki
et al., 1995]. The group exposed at 13:30 hr did
Fig. 1. Nocturnal plasma melatonin concentrations (pg/mL)
after sham, continuous, and intermittent exposure sessions to
a 50 Hz MF of 100 Trms. Each time point is the mean and
S.E.M. of the 21 subjects, from 20.00 to 07.00 hr. The shaded
area represents the period of darkness (light5 lux).
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Fig. 2. Urinary concentrations of aMF6s (ng/hr) in the after-
noon (14.00–19.00 hr), in the evening (19.00–23.00 hr) and in
the night (23.00–07.00 hr) in the three exposure conditions:
sham condition (left), continuous MF exposure (center) and
intermittent MF exposure (right). Arrows indicate the noctur-
nal increase of aMT6s level from the afternoon levels.
intermittent MF exposure (602.170.6 vs.
953.6131.3 ng/hr, P=0.03, F=5.2, d.f.=1,20).
The ANOVAs for repeated measures with pe-
riod of exposure as a covariable, indicated that
there were no differences in afternoon, evening,
and night-time urinary averaged aMT6s concen-
trations between exposure conditions. However,
the difference calculated between night-time and
afternoon levels indicated a tendency for a smaller
increase in night-time aMT6s concentration
(23:00–07:00 hr) compared with the afternoon
level (14:00–19:00 hr) (P=0.08, F=2.47, d.f.=
2,38). Post-hoc analysis indicated that this ten-
dency differentiates continuous MF and sham
conditions. Sixty-six percent (n=14/21) of the
subjects showed this smaller increase, which repre-
sents a difference mean of 85.6 ng/hr (Fig. 2). No
field condition vs. period of exposure was seen in
urinary pineal related parameters.
Based on previous work of Graham et al., we
also tested the difference between individuals ac-
cording to their melatonin secretion and aMT6s
excretion. The plasma data of melatonin obtained
under sham condition were divided at the median
value into a ‘‘Low mel group’’ of 11 men with
sham exposure maximum value less than 55 pg/
mL and a ‘‘High mel group’’ of 10 men with sham
exposure maximum value greater than 55 pg/mL.
No significant difference was found involving ex-
posure condition.
The urinary data of night-time aMT6s obtained
under sham condition were divided at the median
value into a ‘‘Low aMT6s group’’ of 11 men with
sham exposure value less than 626 ng/hr and a
‘‘High aMT6s group’’ of 10 men with sham expo-
sure greater than 626 ng/hr. No significant differ-
ence was found involving exposure condition. But,
when ANOVAs were performed on the two sub-
groups separately, a tendency for a lower increase
of aMT6s levels after continuous MF exposure
from the afternoon to the night (night-time−af-
ternoon measures) was seen in the low group only
(P=0.07, F=3.01, d.f.=2,18). The analysis
showed that order level did not have any influence
on plasma melatonin and aMT6s concentrations
or any interaction with sham or real MF exposure.
Discussion
One frequently cited biological effect of animal
exposure to electric fields and MFs is inhibition or
phase shifting of the normal night-time levels of
melatonin. The consequences of perturbed mela-
tonin production in terms of cancer, depression,
immunity and circadian rhythm disruption is of
great interest in investigating whether or not MF
not differ from the group exposed at 16:30 hr,
based on their plasma melatonin values.
Statistical analysis indicates that plasma mela-
tonin levels were unaltered after MF exposure;
sham, continuous, and intermittent MF exposure
data were not significantly different from one an-
other. No difference was found in maximum mela-
tonin levels between exposure sessions, reaching
7010 (S.E.M.) pg/mL after sham condition, 65
10 pg/mL after continuous and 659 pg/mL after
intermittent MF exposure. Finally, no difference
was found in peak times between the three condi-
tions. Moreover, maximum levels were very repro-
ducible between conditions in the same individual
(correlation coefficients between 0.83 and 0.91,
P=0.0001), indicating that the melatonin excre-
tion profile within the same individual is rather
stable.
The 189 urinary samples showed that aMT6s
concentrations were low during the afternoon, in-
creased in the evening and reached maximum val-
ues at night. The night-time aMT6s excretion
values were significantly lower in the 13:30 hr
group in each of the three experimental condi-
tions: sham (means.E.M.=550.169.1 vs.
1031.1145.1 ng/hr, P=0.01, F=8.4, d.f.=
1,20), continuous MF (542.43.5 vs. 892.5
122.1 ng/hr, P=0.04, F=5.03, d.f.=1,20) and
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exposure may alter concentrations of this hor-
mone in the pineal gland and blood [Wilson et al.,
1989; Reiter, 1995; Ronco and Halberg, 1996;
Stevens et al., 1997; Baldwin and Barrett, 1998].
Little is known, however, of the effective physical
parameters and the mechanisms by which the
fields act on the cells and/or the tissues [Schneider
and Semm, 1992; Portier and Wolfe, 1998].
There have been too few studies on the 50–60
Hz electric field and MF effect on human mela-
tonin concentration to conclude an ELF MF influ-
ence on pineal function. Moreover, in regard to
the occupational studies, no laboratory research
has been conducted to analyse the effect of 50 Hz
MF daytime exposures on melatonin production
in humans. The present study was undertaken to
test the hypothesis that daytime exposure to MF
results in a suppression of the pineal melatonin or
its major urinary metabolite (aMT6s) in humans.
We exposed healthy volunteers to 50 Hz MF of
100 Trms for 30 min in the afternoon and mea-
sured their night-time plasma melatonin and uri-
nary aMT6s concentration profiles. Each subject
was submitted to three experimental conditions:
one sham and two real MF exposures: a continu-
ous one (field on during the 30 min of exposure)
and an intermittent one (15 s on/off cycles) with a
counterbalancing mode of presentation between
subjects and 1 wk between each exposure session.
Although there was no significant difference in
urinary aMT6s level after exposure conditions,
there was a tendency (P=0.08) to a lesser night-
time increase of aMT6s from afternoon level after
continuous MF exposure related to the sham con-
dition. Dividing men into two groups (‘‘Low and
High aMT6s Group’’) according to their aMT6s
night-time values, the same tendency (P=0.07)
was found in the ‘‘Low aMT6s Group’’ only.
There is no reliable evidence that inter-individ-
ual differences in the pineal production of mela-
tonin have to be taken into account. However, it
could be interesting to consider this known inter-
individual difference observed in healthy subjects
[Bergiannaki et al., 1995], according to the diver-
gent results related to this issue [Graham et al.,
1996; Karasek et al., 1998; Wood et al., 1998].
In this study, MF was set at 100 Trms, a field
strength similar to that in the proximity of some
household and industrial electrical appliances or
supply. It is also the limit recommended for gen-
eral public exposure to 50–60 Hz on a continuous
basis by the International Non-ionizing Radiation
Committee of the International Radiation Protec-
tion Association [1998]. However, this study does
not indicate if lower or upper field strength would
be more or less effective in influencing pineal func-
tion. Other characteristics could be of importance
in terms of pineal function including field direc-
tion, duration of exposure, single vs. chronic expo-
sure, rate of change of the electromagnetic
environment, exposure time, individual sensitivity
to light, etc.
In a recent study, Karasek et al. [1998] showed
that 40 Hz daytime MF exposure induced a sig-
nificant depression in nocturnal melatonin rise of
patients with low back pain syndrome, regardless
of time of exposure (10:00 or 18:00 hr). It is the
first study to show that daytime MF exposure can
influence night-time production of melatonin in
controlled conditions. Two main differences with
our study should be underlined: the shape of the
MF (square wave vs. sin wave) and the rate of
exposure (chronic (3 wk, 20 mm/day, 5 days/wk)
vs. single exposure). Again, the particular features
of the experiments should be analysed in determin-
ing the most relevant parameters for pineal func-
tion changes. The latest study of Karasek et al.
[2000] illustrates this assumption. With a MF ex-
posure of 25–80 Trms at 200 Hz, no changes in
melatonin concentrations were observed either af-
ter 1 day or after 1 month following the MF
daytime exposure in comparison with baseline.
Another question raised is why urinary aMT6s
concentrations show results slightly differing from
blood melatonin results, these two parameters be-
ing otherwise highly correlated? The correlation
between night-time concentrations of melatonin in
plasma and urinary aMT6s excretion indicate that
a night-time urine sample is a good index of the
endogenous production of melatonin in plasma, as
previously described in literature [Markey et al.,
1985; Bojklowski et al., 1987; Graham et al.,
1998]. As melatonin has been reported to be
secreted in discrete brief episodes superimposed on
the baseline concentration in humans [Weitzman
et al., 1978; Wetterberg, 1978; Vaughan et al.,
1979], urinary samples also appear to be more
informative than hourly blood values because they
integrate the total production of melatonin [Wet-
terberg, 1978; Cook et al., 1997]. This explains
why small differences could be revealed through
total urine sampling or very close blood sampling.
In conclusion, the nocturnal plasma melatonin
data from this study of 21 men, exposed to these
MF presented continuously (without break) and
intermittently (cycles 15 s on/off) relative to sham
condition, do not support the hypothesis that day-
time exposure to 50–60 Hz MFs alters melatonin
secretion and aMT6s excretion. It is, however, too
early to conclude that pineal function in humans is
unaffected by MF exposure before further examin-
ing the MF effect with different experimental and
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